An expanded clinical trial that tested a groundbreaking, experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and ...

A new stem cell therapy, CALEC, has demonstrated a 92% success rate in regenerating corneas and restoring vision. This ...

An expanded clinical trial that tested an experimental stem cell treatment for blinding cornea injuries found the treatment ...

Mass General Brigham, based in Somerville, Mass., is partnering with Philips to enhance real-time patient monitoring by integrating medical device data into a unified platform, a move aimed at ...

A review of the transaction’s cost and market impact by the Massachusetts Health Policy Commission, released Thursday, raises ...

A union could address a host of issues, including cost-of-living raises, paid sick time, and a definition of “full-time work” ...

Boston Mayor Michelle Wu, alongside more than 40 cities, counties and mayors, filed an amicus brief opposing the Trump ...

In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.

A new local tech safety program is helping victims of domestic violence protect themselves from their abusers.

The latest genome-wide study spanning multiple ancestries offers promising advancements in predicting Alzheimer’s disease ...

While many other retail giants have pulled back on their recent forays into health care, Best Buy (NYSE: BBY) is continuing ...